Products
Imidocarb is commercially available as a solution for injection (Carbesia). It has been approved in many countries since 2011.
Structure and properties
Imidocarb (C19H20N6O, Mr = 348.4 g/mol) is a substituted carbanilide. It is present in drugs as imidocarbdipropionate.
Effects
Imidocarb (ATCvet QP51AE01) has antiparasitic properties against ssp.
Indications
For prevention and treatment of babesiosis in cattle, horses, and dogs.